Literature DB >> 31780470

Cannabis in primary care.

Leon Barron1, Dani Gordon2.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31780470      PMCID: PMC6867223          DOI: 10.3399/bjgp19X706673

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  8 in total

Review 1.  Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.

Authors:  S Lattanzi; E Trinka; E Russo; P Striano; R Citraro; M Silvestrini; F Brigo
Journal:  Drugs Today (Barc)       Date:  2019-03       Impact factor: 2.245

Review 2.  Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads.

Authors:  Ethan B Russo; Jahan Marcu
Journal:  Adv Pharmacol       Date:  2017-06-05

Review 3.  Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

Authors:  Suzanne Nielsen; Pamela Sabioni; Jose M Trigo; Mark A Ware; Brigid D Betz-Stablein; Bridin Murnion; Nicholas Lintzeris; Kok Eng Khor; Michael Farrell; Andrew Smith; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2017-03-22       Impact factor: 7.853

4.  The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study.

Authors:  Simon Haroutounian; Yael Ratz; Yehuda Ginosar; Karina Furmanov; Fayez Saifi; Ronit Meidan; Elyad Davidson
Journal:  Clin J Pain       Date:  2016-12       Impact factor: 3.442

5.  Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain.

Authors:  Kevin F Boehnke; Evangelos Litinas; Daniel J Clauw
Journal:  J Pain       Date:  2016-03-19       Impact factor: 5.820

Review 6.  Cannabidiol as a Potential Treatment for Anxiety Disorders.

Authors:  Esther M Blessing; Maria M Steenkamp; Jorge Manzanares; Charles R Marmar
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

7.  Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden.

Authors:  Yasmina Molero; Henrik Larsson; Brian M D'Onofrio; David J Sharp; Seena Fazel
Journal:  BMJ       Date:  2019-06-12

8.  Potency of Δ9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology.

Authors:  David J Potter; Kathy Hammond; Shaun Tuffnell; Christopher Walker; Marta Di Forti
Journal:  Drug Test Anal       Date:  2018-02-27       Impact factor: 3.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.